Numerous studies have suggested a significant role of selenium in the preve
ntion of gynecological carcinoma. These were epidemiological and prospectiv
e in humans and therapeutic in laboratory animals. However, no studies have
been reported regarding the normal serum selenium levels during pregnancy.
The maternal total blood volume increases 30-50% during the second and thi
rd trimesters, resulting in lower measured serum levels for those metabolit
es, which are not increased significantly during pregnancy. A longitudinal
study of the serum selenium levels in teenage pregnancy during the last two
trimesters and 3 mo postpartum showed progressive elevation from 49 +/- 7
mug/dL after the 32nd week of pregnancy to 114 +/- 7 mug/dL at term, which
was statistically significant (p less than or equal to 0.001). Prenatal sup
plementation with 18 mg of iron per day prevented this elevation. The resul
ts of this study suggest that serum selenium levels in women normally doubl
e during pregnancy and this doubling is prevented by the minimal daily supp
lementation of 18 mg of iron, which may be due to increased absorption of s
elenium into the erythrocytes and incorporation into the glutathione peroxi
dase enzyme.